News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
238 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (4116)
Month
January (4451)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (221)
2 (198)
3 (246)
4 (134)
5 (2)
6 (26)
7 (189)
8 (263)
9 (229)
10 (265)
11 (138)
12 (2)
13 (5)
14 (238)
15 (260)
16 (218)
17 (239)
18 (111)
19 (1)
20 (3)
21 (103)
22 (312)
23 (250)
24 (321)
25 (115)
26 (6)
27 (5)
28 (328)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Drug Development
Denali Seeking “Clear Path Forward” after FDA Clarifies Alzheimer’s Trial Hold
The planned testing for DNL919 was held back pending additional documentation required to initiate the studies and information on the preclinical toxicology assessment.
February 14, 2022
·
2 min read
·
Vanessa Doctor, RN
Business
Maryland’s Biotech Tax Incentive Boosts VC Funding with Guaranteed Returns
Since 2016 the state has offered more than $70 million in tax credits to 114 different entities and has generated about $140 million in investments into the state’s life sciences ecosystem.
February 14, 2022
·
2 min read
·
Alex Keown
Schizophrenia Treatment Market: Rising incidence of this disorder to drive the market
The demand within the global schizophrenia treatment market has been increasing on account of the rising incidence of this disorder.
February 14, 2022
·
5 min read
Prefilled Safety Devices Market: Rising Awareness about Prefilled Safety Devices is Projected to Be a Key Driver of the Growth of the Market
Prefilled safety devices are devices developed as a result of the advancement of innovation in the conventional type of syringes, wherein the needles are created with safety system to anticipate any needle stick or some other needle-related wounds.
February 14, 2022
·
5 min read
Medical Device Complaint Management Market is Expected to Garner A Market Value of US$ Bn 10.52 Bn By 2032
Fact.MR – A Market Research and Competitive Intelligence Provider: The medical device complaint management market has provided a market value of 5.35 bn in 2022.
February 14, 2022
·
7 min read
Global Sales of Endoscopes to Accumulate a Market Value of US$ 34 Bn by 2032
Fact.MR – A Market Research and Competitive Intelligence Provider: The demand for endoscopes has climbed up the market size of endoscope market to 9% CAGR in 2021.
February 14, 2022
·
6 min read
Ambulatory Aids Market: The Walkers Segment is Projected to Account for a Significant Share of the Market
Ambulatory devices are used for proper and stable ambulation in activities such as walking. A wide range of tools comes under the cover of ambulatory aids.
February 14, 2022
·
5 min read
Policy
Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Prevention of Respiratory Syncytial Virus in Older Adults
Bavarian Nordic A/S announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for the Company’s vaccine candidate, MVA-BN RSV, for active immunization for prevention of lower respiratory tract disease caused by respiratory syncytial virus in adults aged 60 years or older.
February 14, 2022
·
5 min read
Genetown
Faron Announces R&D Day
Faron Pharmaceuticals Ltd announces plans to host a virtual R&D Day via webcast on Wednesday, February 23 at 4:00 pm EET, 2:00 pm GMT, 9:00 am EDT.
February 14, 2022
·
5 min read
Business
Kelyniam Global Announces Record Sales and Operating Profit in 2021 Financial Statements
Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2021.
February 14, 2022
·
3 min read
Previous
2 of 24
Next